Complement Gene Single Nucleotide Polymorphisms and Biomarker Endophenotypes of Alzheimer's Disease
(2013) In Journal of Alzheimer's Disease 35(1). p.51-57- Abstract
- The complement system has been implicated in both physiological synapse elimination and Alzheimer's disease (AD). Here, we investigated associations between four single nucleotide polymorphisms (SNPs) in complement genes and cerebrospinal fluid (CSF) biomarkers for AD in 452 neurochemically or neuropathologically verified AD cases and 678 cognitively normal controls. None of the SNPs were associated with risk of AD but there were potential associations of rs9332739 in the C2 gene and rs4151667 in the complement factor B gene with CSF tau levels (p = 0.023) and Mini-Mental State Examination scores (p = 0.012), both of which may be considered markers of disease intensity/severity.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3749523
- author
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Alzheimer's disease, complement, microglia, single nucleotide, polymorphisms
- in
- Journal of Alzheimer's Disease
- volume
- 35
- issue
- 1
- pages
- 51 - 57
- publisher
- IOS Press
- external identifiers
-
- wos:000316940000004
- scopus:84876383039
- ISSN
- 1387-2877
- DOI
- 10.3233/JAD-121930
- language
- English
- LU publication?
- yes
- id
- 45f69ab8-2839-46f6-b8d4-17d02e9cc443 (old id 3749523)
- date added to LUP
- 2016-04-01 09:55:14
- date last changed
- 2022-02-17 04:54:41
@article{45f69ab8-2839-46f6-b8d4-17d02e9cc443, abstract = {{The complement system has been implicated in both physiological synapse elimination and Alzheimer's disease (AD). Here, we investigated associations between four single nucleotide polymorphisms (SNPs) in complement genes and cerebrospinal fluid (CSF) biomarkers for AD in 452 neurochemically or neuropathologically verified AD cases and 678 cognitively normal controls. None of the SNPs were associated with risk of AD but there were potential associations of rs9332739 in the C2 gene and rs4151667 in the complement factor B gene with CSF tau levels (p = 0.023) and Mini-Mental State Examination scores (p = 0.012), both of which may be considered markers of disease intensity/severity.}}, author = {{Daborg, Jonny and Holmgren, Sandra and Abramsson, Alexandra and Andreasson, Ulf and Zetterberg, Madeleine and Nilsson, Staffan and Minthon, Lennart and Skoog, Ingmar and Blennow, Kaj and Pekna, Marcela and Hanse, Eric and Zetterberg, Henrik}}, issn = {{1387-2877}}, keywords = {{Alzheimer's disease; complement; microglia; single nucleotide; polymorphisms}}, language = {{eng}}, number = {{1}}, pages = {{51--57}}, publisher = {{IOS Press}}, series = {{Journal of Alzheimer's Disease}}, title = {{Complement Gene Single Nucleotide Polymorphisms and Biomarker Endophenotypes of Alzheimer's Disease}}, url = {{http://dx.doi.org/10.3233/JAD-121930}}, doi = {{10.3233/JAD-121930}}, volume = {{35}}, year = {{2013}}, }